Oncologist, MD, MPM
Expert in Personalized Medicine & Oncology Strategy |
2009
MD - University of Southern Denmark
2022
Specialization in Clinical Oncology
2022 – Present
Department of Oncology, Zealand University Hospital: Principal Investigator of the ProTarget Study, focusing on tailored treatment strategies in oncology. Steering Committee Member of the Personalized Medicine Program, responsible for implementing whole-genome sequencing for patients with solid tumors in Zealand.
2023 – 2024
Danish Medicines Council: Specialist Committee Member for tumor-agnostic drugs, evaluating innovative treatment modalities.
2023 – Present
Danish National Tumor Board: Member of the Steering Committee, advancing precision oncology approaches
2024
Master of personalized medicine
2024
Course Leadership: Clinically Applied Personalized Medicine, in collaboration with Rigshospitalet Phase 1 Unit.
Lise Søndergaard - Work Experience
2024 -
Course Leadership: Clinically Applied Personalized Medicine, in collaboration with Rigshospitalet Phase 1 Unit
2023 -
Danish National Tumor Board: Member of the Steering Committee, advancing precision oncology approaches
2023 - 2024
Danish Medicines Council: Specialist Committee Member for tumor-agnostic drugs, evaluating innovative treatment modalities
2022 -
Department of Oncology, Zealand University Hospital:
-
Principal Investigator, ProTarget Study, focusing on tailored treatment strategies in oncology.
-
Steering Committee Member, Personalized Medicine Program, responsible for implementing whole-genome sequencing for patients with solid tumors in Zealand.